On August 7, 2023, the company announced that it has extended the offering period. The transaction is now expected to close on September 14, 2023,
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,915 KRW | -8.91% | -.--% | -22.27% |
1st Jan change | Capi. | |
---|---|---|
-22.27% | 64.47M | |
+19.10% | 125B | |
+14.01% | 108B | |
-3.72% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-11.96% | 16.5B | |
+2.96% | 13.39B | |
+27.66% | 11.1B |
- Stock Market
- Equities
- A208340 Stock
- News PharmAbcine Inc.
- PharmAbcine Inc. announced extension to the offering period